Neuropathy, skin rash, and hyperglycemia following enfortumab vedotin treatment were associated with improved PFS in ...

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) announced that data from its US and UK first-in-human dose escalation ...

In recognition of International Childhood Cancer Day, a warning has been issued about the most common form of the disease in ...

Corbus Pharmaceuticals (CRBP) stock drops 12% after mixed Phase 1 trial results for its lead cancer candidate. Read more here.

Dr. Natalie Klar, MD, a breast oncologist at NYU Langone’s Perlmutter Cancer Center, says that every woman is at risk for ...

Alli McLaren uses her social media page to open up about her health journey. She claimed her former doctor "ignored" five key ...

Large-scale construction projects involving drilling and demolition generate significant dust, requiring teams to navigate ...

Casas, MD, discusses a systematic review of recent trials examining objective response rate and adverse events of antibody drug conjugate (ADC) combinations in advanced urothelial cancer.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

ShareThe scene Miss OMG just couldn’t wait to hang out with BJ (her boyfriend of 6 weeks), excitedly they strolled and ...

Amazon has become the go-to online shopping mall for everything from dog food and doorknobs to bedding and bestsellers for ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...